Susan K Gilmour Selected Research

Neuroblastoma

9/2016	Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression.
7/2015	Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma.
12/2008	ODC1 is a critical determinant of MYCN oncogenesis and a therapeutic target in neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susan K Gilmour Research Topics

Disease

27	Neoplasms (Cancer) 10/2023 - 01/2002
10	Carcinogenesis 07/2019 - 01/2005
3	Melanoma (Melanoma, Malignant) 01/2021 - 07/2013
3	Inflammation (Inflammations) 07/2019 - 09/2011
3	Neoplasm Metastasis (Metastasis) 12/2016 - 11/2010
3	Neuroblastoma 09/2016 - 12/2008
2	Starvation 10/2023 - 10/2017
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 12/2016
2	Skin Neoplasms (Skin Cancer) 01/2019 - 11/2007
2	Breast Neoplasms (Breast Cancer) 07/2013 - 11/2010
1	Snyder Robinson syndrome 11/2023
1	Obesity 07/2019
1	Fatty Liver 07/2019
1	Non-alcoholic Fatty Liver Disease 07/2019
1	Hypertriglyceridemia 07/2019
1	Ascites 12/2016
1	African Trypanosomiasis (Nagana) 07/2015
1	Encephalitis (Encephalitis, Rasmussen) 07/2015
1	Hyperplasia 09/2011
1	Wounds and Injuries (Trauma) 09/2011
1	Contact Dermatitis (Eczema, Contact) 01/2011
1	Weight Loss (Weight Reduction) 11/2010
1	Neoplasm Micrometastasis 11/2010
1	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2008

Drug/Important Bio-Agent (IBA)

23	PolyaminesIBA 11/2023 - 01/2002
9	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 03/2014 - 01/2005
8	EnzymesIBA 11/2023 - 01/2002
7	Eflornithine (Ornidyl)FDA Link 01/2022 - 01/2002
4	Thrombin FDA Link 01/2022 - 11/2010
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 08/2006
3	FibrinIBA 01/2022 - 11/2010
3	Proteinase-Activated ReceptorsIBA 01/2022 - 11/2010
3	Dabigatran FDA Link 12/2016 - 11/2010
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 12/2016
2	CytokinesIBA 01/2022 - 12/2016
2	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 11/2010
2	LigandsIBA 01/2021 - 07/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 12/2016
2	PLX 4720IBA 01/2021 - 01/2018
2	matrigelIBA 01/2021 - 11/2010
2	AntithrombinsIBA 12/2016 - 11/2010
2	Thromboplastin (Tissue Factor)IBA 12/2016 - 01/2015
2	CarcinogensIBA 09/2011 - 11/2010
2	Protein Isoforms (Isoforms)IBA 08/2007 - 08/2006
2	Transcription Factors (Transcription Factor)IBA 08/2007 - 08/2006
2	Histone Acetyltransferases (Histone Acetyltransferase)IBA 08/2006 - 01/2002
2	Histones (Histone)IBA 11/2003 - 01/2002
2	ChromatinIBA 11/2003 - 01/2002
1	Spermine SynthaseIBA 11/2023
1	Amino Acids FDA Link 10/2023
1	Arginine (L-Arginine)FDA Link 10/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	rucaparibIBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Chemotactic FactorsIBA 01/2021
1	Immune Checkpoint InhibitorsIBA 10/2020
1	Meglumine FDA Link 07/2019
1	Toll-Like Receptor 4IBA 01/2019
1	HMGB1 Protein (HMG1)IBA 01/2019
1	ArsenicIBA 01/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2018
1	Granzymes (Granzyme)IBA 10/2017
1	Peptides (Polypeptides)IBA 10/2017
1	AntigensIBA 10/2017
1	Interleukin-10 (Interleukin 10)IBA 12/2016
1	Cisplatin (Platino)FDA LinkGeneric 12/2016
1	CationsIBA 09/2016
1	Celecoxib (Celebrex)FDA Link 09/2016
1	Complement System Proteins (Complement)IBA 07/2015
1	ArginaseIBA 01/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2015
1	Oxidoreductases (Dehydrogenase)IBA 03/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2014
1	anthraceneIBA 03/2014
1	afimoxifene (hydroxytamoxifen)IBA 03/2014
1	DiaminesIBA 07/2013
1	naphthaleneIBA 07/2013
1	butaneIBA 07/2013
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2011
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 09/2011
1	Extracellular Matrix ProteinsIBA 11/2007
1	PutrescineIBA 11/2007
1	CREB-Binding ProteinIBA 08/2007
1	Messenger RNA (mRNA)IBA 08/2006
1	TeaIBA 01/2005
1	PolyphenolsIBA 01/2005
1	Drinking WaterIBA 01/2005
1	Nucleosomes (Nucleosome)IBA 11/2003
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2002

Therapy/Procedure

8	Therapeutics 10/2023 - 11/2010
2	Immunotherapy 10/2020 - 07/2015
2	Drug Therapy (Chemotherapy) 09/2016 - 07/2015
2	Oral Administration 01/2015 - 11/2010
1	Radiotherapy 07/2015
1	Neoadjuvant Therapy 03/2014
1	Chemoprevention 11/2007